Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc. (SRPT)'s share was trading at $124.47 as of Dec 12^th. SRPT’s trailing and forward P/E were 80.82 and 10.07 respectively according to Yahoo Finance.

[caption id="attachment_1223386" align="aligncenter" width="768"] A scientist carefully examining a petri dish containing a rare disease's gene therapy.[/caption]

Sarepta Therapeutics is a pioneering biotechnology company focused on...